Serial #98137239
LIVE

Serial Number

98137239

Owner

RECURSION PHARMACEUTICALS, INC.

Attorney

David Johnson

First Use Date

Jul 26, 2023

Filing Date

Aug 17, 2023

Add to watchlist:

No watchlists yet
View on USPTO

Serial #98137239 Trademark

Serial Number: 98137239 • Registration: 7779988

Serial #98137239 is a trademark filed by RECURSION PHARMACEUTICALS, INC. on August 17, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

RECURSION PHARMACEUTICALS, INC. (37 trademarks)

41 SOUTH RIO GRANDE STREET
SALT LAKE CITY, UT 84101

Entity Type: 03

Trademark Details

Filing Date

August 17, 2023

Registration Date

April 29, 2025

First Use Anywhere

July 26, 2023

First Use in Commerce

July 26, 2023

Published for Opposition

May 21, 2024

Goods & Services

Pharmaceutical research and development services; Scientific research and development of pharmaceutical preparations; Pharmaceutical research services, namely, developing new uses for pharmaceutical compounds through the use of computer models, animal models, and controlled environments; Contract research services in support of scientific research and development of pharmaceutical preparations; Technical consultancy and services in relation to technical research in the field of pharmaceuticals; Consultancy in relation to scientific research in the field of pharmaceuticals; Providing medical research and scientific research information in the field of medicine and pharmaceuticals; Drug discovery services; Drug use discovery services; scientific and technological services, namely, medical laboratories, scientific research and design for others in the field of pharmaceuticals, conducting and evaluating clinical trials; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; Providing an online searchable database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding; Providing an online database in the fields of pharmaceutical research and development, scientific research and development of pharmaceutical preparations, developing new uses for pharmaceutical compounds, technical research in the field of pharmaceuticals, drug use, drug discovery, and biology understanding

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 29, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 29, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 7, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 7, 2025 CNPR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 19, 2025 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Mar 18, 2025 SUPC
SOU EXTENSION 1 GRANTED
Mar 18, 2025 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 18, 2025 AITU
USE AMENDMENT FILED
Jan 15, 2025 IUAF
SOU EXTENSION 1 FILED
Jan 15, 2025 EXT1
TEAS STATEMENT OF USE RECEIVED
Jan 15, 2025 EISU
SOU TEAS EXTENSION RECEIVED
Jan 15, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 16, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 21, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 1, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 17, 2024 CNSA
ASSIGNED TO EXAMINER
Apr 17, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 16, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2023 NWOS
NEW APPLICATION ENTERED
Aug 21, 2023 NWAP